Arcadia Biosciences, Inc. (47)
Browse by Contract Category
Contracts
-
Form Securities Purchase Agreement
(Filed With SEC on August 16, 2022)
-
Form of Placement Agent Preferred Investment Option
(Filed With SEC on August 16, 2022)
-
Employment letter for Stanley E. Jacot, Jr., Chief Executive Officer
(Filed With SEC on May 12, 2022)
-
Amendment No. 9 to the Office Lease dated March 17, 2003 between the Registrant and Pac West Office Equities, LP
(Filed With SEC on August 13, 2020)
-
Limited Liability Company Operating Agreement for Archipelago Ventures Hawaii, LLC, dated as of August 9, 2019
(Filed With SEC on August 9, 2019)
-
Form of Preferred Investment Option
(Filed With SEC on August 16, 2022)
-
Form of Pre-Funded Warrant
(Filed With SEC on August 16, 2022)
-
Severance and Change In Control Agreement for Chris Cuvelier
(Filed With SEC on March 31, 2022)
-
Inducement Option Grant for Stanley Jacot
(Filed With SEC on February 7, 2022)
-
Severance Agreement
(Filed With SEC on February 7, 2022)
-
Separation and Release Agreement
(Filed With SEC on December 20, 2021)
-
Employment letter for Laura Pitlik, Chief Marketing Officer
(Filed With SEC on November 15, 2021)
-
Severance and Change In Control Agreement for Laura Pitlik
(Filed With SEC on November 15, 2021)
-
Transition Agreement
(Filed With SEC on September 7, 2021)
-
Employment letter for Chris Cuvelier, Chief Growth Officer
(Filed With SEC on August 16, 2021)
-
Inducement Option Grant for Chris Cuvelier
(Filed With SEC on May 21, 2021)
-
Asset Purchase Agreement dated May 17, 2021, by and among Arcadia, Buyer, Seller, Eko, Lief, Zola and Parent
(Filed With SEC on May 21, 2021)
-
Form of Registration Rights Agreement dated as of January 25, 2021, between Arcadia Biosciences, Inc. and each purchaser named on the signature pages thereto
(Filed With SEC on January 29, 2021)
-
Form of Securities Purchase Agreement dated as of January 25, 2021, between Arcadia Biosciences, Inc. and each purchaser named on the signature pages thereto
(Filed With SEC on January 29, 2021)
-
Form of Placement Agent Warrant
(Filed With SEC on January 29, 2021)
-
Form of Investor Warrant
(Filed With SEC on January 29, 2021)
-
Form of Investor Warrant
(Filed With SEC on December 22, 2020)
-
Master Transaction Agreement
(Filed With SEC on December 22, 2020)
-
Form of Securities Purchase Agreement dated as of December 18, 2020, between Arcadia Biosciences, Inc. and each purchaser named on the signature pages thereto
(Filed With SEC on December 22, 2020)
-
Form of Placement Agent Warrant
(Filed With SEC on December 22, 2020)
-
Form of Placement Agent Warrant issued on July 8, 2020
(Filed With SEC on July 8, 2020)
-
Form of Letter Agreement, dated as of July 6, 2020
(Filed With SEC on July 8, 2020)
-
Form of New Warrant issued on July 8, 2020
(Filed With SEC on July 8, 2020)
-
Loan Agreement, dated May 18, 2020, by and between MidFirst Bank and Arcadia Biosciences, Inc
(Filed With SEC on July 2, 2020)
-
Promissory Note, dated June 26, 2020, by and between MidFirst Bank and Arcadia Biosciences, Inc
(Filed With SEC on July 2, 2020)
-
Pledge and Security Agreement dated May 18, 2020, by and between MidFirst Bank and Arcadia Biosciences, Inc
(Filed With SEC on July 2, 2020)
-
Form of Letter Agreement, dated as of May 14, 2020
(Filed With SEC on May 18, 2020)
-
Form of Placement Agent Warrant issued on May 18, 2020
(Filed With SEC on May 18, 2020)
-
Form of New Warrant issued on May 18, 2020
(Filed With SEC on May 18, 2020)
-
Promissory Note, dated April 16, 2020, by and between MidFirst Bank and Arcadia Biosciences, Inc
(Filed With SEC on April 21, 2020)
-
Description of Registrant's Securities Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
(Filed With SEC on March 25, 2020)
-
Amendment No. 8 to the Office Lease dated March 17, 2003 between the Registrant and Pac West Office Equities, LP
(Filed With SEC on March 25, 2020)
-
Form of Securities Purchase Agreement dated as of September 5, 2019, between Arcadia Biosciences, Inc. and each purchaser named in the signature pages thereto
(Filed With SEC on September 9, 2019)
-
Form of Placement Agent Warrant
(Filed With SEC on September 9, 2019)
-
Form of Warrant
(Filed With SEC on September 9, 2019)
-
Separation and Release Agreement for Rajendra Ketkar, dated as of August 23, 2019
(Filed With SEC on August 28, 2019)
-
Offer Letter and appended form of Severance and Change In Control Agreement between the Registrant and Sarah Reiter, dated February 16, 2018
(Filed With SEC on July 26, 2019)
-
2015 Omnibus Equity Incentive Plan and forms of agreement thereunder
(Filed With SEC on July 26, 2019)
-
Form of Placement Agent Warrant
(Filed With SEC on June 14, 2019)
-
Form of Warrant
(Filed With SEC on June 14, 2019)
-
Form of Securities Purchase Agreement dated as of June 12, 2019, between Arcadia Biosciences, Inc. and each purchaser named in the signature pages thereto
(Filed With SEC on June 14, 2019)
-
Amended and Restated 2015 Omnibus Equity Incentive Plan
(Filed With SEC on June 7, 2019)
